Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occur in both nostrils in those who are affected. Complications may include sinusitis and broadening of the nose.
This report contains market size and forecasts of Nasal Polyps Drugs in Global, including the following market information:
- Global Nasal Polyps Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nasal Polyps Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nasal Polyps Drugs include Pfizer, Roche, Sanofi, Novartis, GlaxoSmithKline, Merck and Regeneron Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nasal Polyps Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nasal Polyps Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nasal Polyps Drugs Market Segment Percentages, by Type, 2021 (%)
- Corticosteroids
- Antibiotics
- Leukotriene Inhibitors
- Others
Global Nasal Polyps Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nasal Polyps Drugs Market Segment Percentages, by Application, 2021 (%)
Global Nasal Polyps Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nasal Polyps Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Nasal Polyps Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Nasal Polyps Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Roche
- Sanofi
- Novartis
- GlaxoSmithKline
- Merck
- Regeneron Pharmaceuticals
